Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company is 'the gorilla in the room that people didn’t see coming'

The Hydroponics Company (ASX:THC) chief executive Ken Charteris explains to Proactive Investors the company’s international, vertically-integrated operations in both the hydroponics and medical cannabis sectors.

The company has made rapid advancements into the medical cannabis space, thanks in large part to numerous strategic alliances with significant global operators, and key acquisitions. Charteris explains, “now we have a medical cannabis company with the largest manufacturing plant in the southern hemisphere, thanks to a recent acquisition from a major pharmaceutical company. We have a fully-licensed growing facility in Bundaberg. We just recently [gained] the rights to another growing facility in northern New South Wales. As everybody understands, the sector in Australia is still in its development stages for patient applications, however the opportunity to export… brings a great amount of opportunity for this company.”

As of July 23rd, the first product will be available to doctors to prescribe under Special Access Scheme in Australia. With the licensing process on the manufacturing plant in the final stages now, the company is looking to commence exports of pharmaceutical-grade cannabis by Q1 next year. Charteris says, “we’re sort of like the gorilla in the room that people didn’t see coming… the asset base and team have been built to support that.”

“We actually are now really a truly international medical cannabis company, but we should not forget our roots as a hydroponics company out of Canada, which we are building out with more alliances which we will be reporting shortly,” teases Charteris.

Join our Crypto, Blockchain and Cannabis Telegram group here  
Meet Arix Bioscience Plc, Avacta Group Plc and Silence Therapeutics plc at our event, London , 04 October 2018. Register here »
View full THC profile View Profile

The Hydroponics Company Timeline

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use